Brief: Briacell Therapeutics Announces Pricing Of $30 Million Public Offering At $5.59 Per Unit
14/01/2026 02:01
Jan 13 (Reuters) - Briacell Therapeutics Corp BCT.TO: BRIACELL THERAPEUTICS ANNOUNCES PRICING OF $30 MILLION PUBLIC OFFERING BRIACELL THERAPEUTICS CORP - UNITS SOLD AT $5.59 PER UNIT FOR $30 MILLION GROSS PROCEEDS Source text: ID:nGNX7FtrCj Further company coverage: BCT.TO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Briacell Therapeutics
See all newsBrief: Briacell Therapeutics Prices 1.45 Million Common Shares At $3.25 Per Share
Brief: Briacell Receives Positive Recommendation From Data Safety Monitoring Board (Dsmb) For Phase 3 Study In Metastatic Breast Cancer
Brief: Briacell Expands Pipeline To Include An Ovarian Cancer Immunotherapy Candidate, Bria-Ova+™
Brief: Briacell Phase 3 Bria-Imt™ Study Enrollment Surpasses 230 Patients
Brief: Briacell Adds Nyu Langone Health’S Perlmutter Cancer Center As Clinical Site In Pivotal Phase 3 Breast Cancer Study